Available: http:// www.unaids.org/en/HIV_data, Report on the global AIDS epidemic, 2006. ,
Immunization of children at risk of infection with human immunodeficiency virus, Bull World Health Organ, vol.81, pp.61-70, 2003. ,
Immunization for Persons Infected with Human Immunodeficiency Virus, Current HIV Research, vol.2, issue.4, pp.293-299, 2004. ,
DOI : 10.2174/1570162043351084
Transfer and Evaluation of an Automated, Low-Cost Real-Time Reverse Transcription-PCR Test for Diagnosis and Monitoring of Human Immunodeficiency Virus Type 1 Infection in a West African Resource-Limited Setting, Journal of Clinical Microbiology, vol.43, issue.6, pp.2709-2717, 2005. ,
DOI : 10.1128/JCM.43.6.2709-2717.2005
Neonatal Measles Immunity in Rural Kenya: The Influence of HIV and Placental Malaria Infections on Placental Transfer of Antibodies and Levels of Antibody in Maternal and Cord Serum Samples, The Journal of Infectious Diseases, vol.191, issue.11, pp.1854-1860, 2005. ,
DOI : 10.1086/429963
Measles immunity testing: Comparison of two measles IgG ELISAs with plaque reduction neutralisation assay, Journal of Virological Methods, vol.131, issue.2, pp.209-212, 2006. ,
DOI : 10.1016/j.jviromet.2005.08.001
Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal, Vaccine, vol.9, issue.11, pp.843-850, 1991. ,
DOI : 10.1016/0264-410X(91)90224-T
Prognostic Markers Collaborative Study Group (2003) Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis, Lancet, vol.362, pp.1605-1611 ,
The development of MUAC-for-age reference data recommended by a WHO Expert Committee, Bull World Health Organ, vol.75, pp.11-18, 1997. ,
HIV-1 Infection as a Risk Factor for Incomplete Childhood Immunization in Zambia, Journal of Tropical Pediatrics, vol.52, issue.5, pp.324-328, 2006. ,
DOI : 10.1093/tropej/fmk002
Evaluating the impact of the HIV pandemic on measles control and elimination, Bull World Health Organ, vol.83, pp.329-337, 2005. ,
Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study, The Lancet, vol.369, issue.9557, pp.191-200, 2007. ,
DOI : 10.1016/S0140-6736(07)60107-X
Responses to measles immunization in children infected with human immunodeficiency virus, The Journal of Pediatrics, vol.125, issue.1, pp.72-74, 1994. ,
DOI : 10.1016/S0022-3476(94)70125-3
Measles antibody in vaccinated human immunodeficiency virus type 1-infected children, Pediatrics, vol.97, pp.653-657, 1996. ,
Search of antimeasles antibodies in HIV-infected children after basic immunization, Jornal de Pediatria, vol.77, issue.6, pp.496-502, 2001. ,
DOI : 10.2223/JPED.360
Safety and Immunogenicity of High-Dose Edmonston-Zagreb Measles Vaccine in Children With HIV-1 Infection, American Journal of Diseases of Children, vol.146, issue.5, pp.550-555, 1992. ,
DOI : 10.1001/archpedi.1992.02160170030011
Child mortality after high-titre measles vaccines: prospective study in Senegal, The Lancet, vol.338, issue.8772, pp.903-907, 1991. ,
DOI : 10.1016/0140-6736(91)91771-L
The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda, International Journal of Epidemiology, vol.28, issue.2, pp.341-346, 1999. ,
DOI : 10.1093/ije/28.2.341
Unacceptably High Mortality Related to Measles Epidemics in Niger, Nigeria, and Chad, medicine.plosjournals.org via the Internet. Accessed 17, 2007. ,
DOI : 10.1371/journal.pmed.0040016.sd002
Measles Still Has a Devastating Impact in Unvaccinated Populations, PLoS Medicine, vol.366, issue.1, p.24, 2007. ,
DOI : 10.1371/journal.pmed.0040024.g001
Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination, Vaccine, vol.18, issue.14, pp.1393-1401, 2000. ,
DOI : 10.1016/S0264-410X(99)00396-5
Immune Responses to Measles and Mumps Vaccination of Infants at 6, 9, and 12 Months, The Journal of Infectious Diseases, vol.184, issue.7, pp.817-826, 2001. ,
DOI : 10.1086/323346
Decrease in Measles Virus???Specific CD4 T Cell Memory in Vaccinated Subjects, The Journal of Infectious Diseases, vol.190, issue.8, pp.1387-1395, 2004. ,
DOI : 10.1086/424571
Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children, Pediatr Infect Dis J, vol.14, pp.149-151, 1995. ,
Abnormalities of Measles Antibody Response in Human Immunodeficiency Virus Type 1 (HIV-1) Infection, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.10, issue.5, pp.540-548, 1995. ,
DOI : 10.1097/00042560-199510050-00007
Persistent Humoral Immune Defect in Highly Active Antiretroviral Therapy-Treated Children With HIV-1 Infection: Loss of Specific Antibodies Against Attenuated Vaccine Strains and Natural Viral Infection, PEDIATRICS, vol.118, issue.2, pp.315-322, 2006. ,
DOI : 10.1542/peds.2005-2616
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis, The Lancet, vol.364, issue.9441, pp.1236-1243, 2004. ,
DOI : 10.1016/S0140-6736(04)17140-7
Pathogenesis of HIV infection: what the virus spares is as important as what it destroys, Nature Medicine, vol.168, issue.3, pp.289-295, 2006. ,
DOI : 10.1038/nm1380
HIV disease: fallout from a mucosal catastrophe?, Nature Immunology, vol.438, issue.3, pp.235-239, 2006. ,
DOI : 10.1038/ni1316
Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993, The Pediatric Infectious Disease Journal, vol.15, issue.6, pp.479-485, 1988. ,
DOI : 10.1097/00006454-199606000-00003
Morbidity Among Human Immunodeficiency Virus-1-Infected and -Uninfected African Children, PEDIATRICS, vol.106, issue.6, p.77, 2000. ,
DOI : 10.1542/peds.106.6.e77
Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study, The Lancet, vol.369, issue.9571, pp.1440-1451, 2007. ,
DOI : 10.1016/S0140-6736(07)60670-9
T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV, Blood, vol.96, pp.3866-3871, 2000. ,
Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers, AIDS, vol.21, issue.2, pp.245-248, 2007. ,
DOI : 10.1097/QAD.0b013e328011d7d3
Immunization in children with HIV seropositivity at birth, AIDS, vol.6, issue.12, pp.1465-1469, 1992. ,
DOI : 10.1097/00002030-199212000-00007
Safety and immunogenicity of bacille Calmette-Gu??rin, diphtheria-tetanuspertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1, The Journal of Pediatrics, vol.122, issue.5, pp.697-702, 1993. ,
DOI : 10.1016/S0022-3476(06)80007-7
Trial of a Supplemental Dose of Four Poliovirus Vaccines, New England Journal of Medicine, vol.343, issue.11, pp.767-773, 2000. ,
DOI : 10.1056/NEJM200009143431103
Influence of host related factors on the antibody response to trivalent oral polio vaccine in Tunisian infants, Vaccine, vol.15, issue.10, pp.1123-1129, 1997. ,
DOI : 10.1016/S0264-410X(97)00001-7
Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, C??te d'Ivoire, AIDS, vol.18, issue.14, pp.1905-1913, 2004. ,
DOI : 10.1097/00002030-200409240-00006
Early versus Deferred Antiretroviral Multidrug Therapy in Infants Infected with HIV Type 1, Clinical Infectious Diseases, vol.39, issue.11, pp.1692-1698, 2004. ,
DOI : 10.1086/425739
Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection., AIDS, vol.20, issue.2, pp.207-215, 2006. ,
DOI : 10.1097/01.aids.0000200529.64113.3e